ZURA
#2814
Zura Bio Limited - Class A Ordinary shares
6.2 3 USD
+0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+5.95%
Monthly Change
+8.54%
6 month change
-4.89%
Year Change
+184.47%
Previous Close
5.8 8
Open
6.2 3
Low
6.2 3
High
6.2 3
Volume
58
Financials
- Market Capitalization 597.02 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.22
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2808 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 30.75 USD | +2.77% | -13.79% | +2.81% | +79.30% | 601.14 M USD | ||
| 2811 |  VALN Valneva SE - American Depositary Shares | 6.89 USD | -2.41% | +8.50% | +29.51% | -18.56% | 597.84 M USD | ||
| 2815 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 2.24 USD | -2.18% | -3.45% | +14.87% | +51.35% | 596.20 M USD | ||
| 2821 |  RGNX REGENXBIO Inc. - Common Stock | 8.94 USD | -2.83% | -5.89% | -20.74% | -33.43% | 590.16 M USD |
Frequently asked questions about Zura Bio Limited Class A Ordinary Shares
What is the Zura Bio Limited Class A Ordinary Shares stock price today?
The current price of Zura Bio Limited Class A Ordinary Shares (ZURA) is 6.23. Over the past 24 hours, the stock has changed by +5.95%. Follow the ZURA chart for real-time price dynamics.
What is the stock ticker of Zura Bio Limited Class A Ordinary Shares?
Zura Bio Limited Class A Ordinary Shares trades under the ticker ZURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zura Bio Limited Class A Ordinary Shares stock going up?
ZURA has changed by +9.68% over the last week, +8.54% over the last month, and +184.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Zura Bio Limited Class A Ordinary Shares?
Zura Bio Limited Class A Ordinary Shares currently has a market capitalization of 597.02 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Zura Bio Limited Class A Ordinary Shares earnings last quarter?
Last quarter, Zura Bio Limited Class A Ordinary Shares reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Zura Bio Limited Class A Ordinary Shares revenue for the last quarter?
Zura Bio Limited Class A Ordinary Shares reported quarterly revenue of 4 949. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Zura Bio Limited Class A Ordinary Shares net income for the last quarter?
Zura Bio Limited Class A Ordinary Shares reported net income of -26.3 M for the last quarter. The previous quarter showed -24.22 M, which means net income changed by -8.59%.
How many employees does Zura Bio Limited Class A Ordinary Shares have?
As of the latest available data, Zura Bio Limited Class A Ordinary Shares has 40 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Zura Bio Limited Class A Ordinary Shares stock?
You can buy Zura Bio Limited Class A Ordinary Shares (ZURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zura Bio Limited Class A Ordinary Shares stock?
Investing in Zura Bio Limited Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZURA chart and related analysis on metatrader.com as part of your research.